Increased Mitochondrial Mass Characterizes the Survival Defect of HIV-specific CD8(+) T Cells
Overview
Authors
Affiliations
What governs the increased apoptosis sensitivity of HIV-specific CD8(+) T cells is poorly understood. Here, we examined the involvement of mitochondria in this apoptosis. Remarkably higher mitochondrial mass (MM) was found in HIV-specific compared with CMV-specific CD8(+) T cells from HIV(+) patients and this could not be attributed to their different differentiation status. MM(High) phenotype characterized those CD8(+) T cells from HIV(+) patients that are sensitive to spontaneous and CD95/Fas-induced apoptosis. CD38 expression did not correlate with high MM, whereas Bcl-2 levels were significantly reduced in both CD38(+) and CD38(-) HIV-specific CD8(+) T cells. Although CD38(+) HIV-specific CD8(+) T cells were more susceptible to apoptosis, CD38 expression does not explain on its own the selective apoptosis sensitivity of HIV-specific CD8(+) T cells, as CD38(-) HIV-specific CD8(+) T cells were more apoptotic than CD38(+) CMV-specific ones. Proapoptotic HIV-specific CD8(+) T cells were CD38(+)Bcl-2(Low)MM(High). Copolarization of mitochondria with CD95/Fas capping, very early in CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells, suggests that mitochondria act as an amplification step for this apoptosis. Thus, an extensive mitochondrial network contributes to apoptosis sensitivity of CD8(+) T cells and, when this occurs together with reduced levels of Bcl-2 and chronic activation, determines the proapoptotic state of HIV-specific CD8(+) T cells.
Analysis of mitochondrial function in lymphocytes obtained from COVID-19 patients.
He Z, Liu J, Ma S Int J Immunopathol Pharmacol. 2023; 37:3946320231210736.
PMID: 37889851 PMC: 10612433. DOI: 10.1177/03946320231210736.
Akiso M, Ameka M, Naidoo K, Langat R, Kombo J, Sikuku D PLoS One. 2023; 18(10):e0286436.
PMID: 37816026 PMC: 10564234. DOI: 10.1371/journal.pone.0286436.
Alrubayyi A, Moreno-Cubero E, Hameiri-Bowen D, Matthews R, Rowland-Jones S, Schurich A Front Immunol. 2022; 13:908697.
PMID: 35865519 PMC: 9295450. DOI: 10.3389/fimmu.2022.908697.
Jankauskaite E, Ambroziak A, Hajieva P, Oldak M, Tonska K, Korwin M J Appl Genet. 2020; 61(2):195-203.
PMID: 32157656 PMC: 7148285. DOI: 10.1007/s13353-020-00550-y.
Butterfield T, Landay A, Anzinger J Curr HIV/AIDS Rep. 2020; 17(2):125-137.
PMID: 32140979 PMC: 8760627. DOI: 10.1007/s11904-020-00484-4.